References
- Reiss HE. Historical insights: John William Ballantyne 1861–1923. Hum Reprod Update. 1999;5(4):386–389.
- Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther. 2010;27(4):191–203.
- Gedikbasi A, Oztarhan K, Gunenc Z, et al. Preeclampsia due to fetal non-immune hydrops: mirror syndrome and review of literature. Hypertens Pregnancy. 2011;30(3):322–330.
- Skoll MA, Sharland GK, Allan LD. Is the ultrasound definition of fluid collections in non-immune hydrops fetalis helpful in defining the underlying cause or predicting outcome? Ultrasound Obstet Gynecol. 1991;1(5):309–312.
- Santolaya J, Alley D, Jaffe R, et al. Antenatal classification of hydrops fetalis. Obstet Gynecol. 1992;79(2):256–259.
- Society for Maternal-Fetal Medicine (SMFM), Norton ME, Chauhan SP, et al. Society for maternal-fetal medicine (SMFM) clinical guideline #7: Nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015;212(2):127–139.
- ACOG Committee on Practice Bulletins. Obstetrics. ACOG Practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;33(January):159–167.
- American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Hypertension in pregnancy; 2013 [cited 2013 December 23]. Available from: http://www.acog.org/Resources_And_Publications/Task_Force_and_Work_Group_Reports/Hypertension_in_Pregnancy
- Espinoza J, Romero R, Nien JK, et al. A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med. 2006;19(10):607–613.
- Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med. 2006;354(17):1857–1858.
- Rana S, Venkatesha S, DePaepe M, et al. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol. 2007;109(2 Pt2):549–552.
- Goa S, Mimura K, Kakigano A, et al. Normalisation of angiogenic imbalance after intra-uterine transfusion for mirror syndrome caused by parvovirus B19. Fetal Diagn Ther. 2013;34(3):176–179.
- Llurba E, Marsal G, Sanchez O, et al. Angiogenic and antiangiogenic factors before and after resolution of maternal mirror syndrome. Ultrasound Obstet Gynecol. 2012;40(3):367–369.
- Bixel K, Silasi M, Zelop CM, et al. Placental origins of angiogenic dysfunction in mirror syndrome. Hypertens Pregnancy. 2012;31(2):211–217.
- Prefumo F, Pagani G, Fratelli N, et al. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin-to-twin transfusion syndrome. Prenat Diagn. 2010;30(4):378–379.
- Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
- Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
- Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
- Heyborne KD, Chism DM. Reversal of Ballantyne syndrome by selective second-trimester fetal termination. A case report. J Reprod Med. 2000;45(4):360–362.
- Pirhonen JP, Hartgill TW. Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death. Eur J Obstet Gynecol Reprod Biol. 2004;116(1):106–107.
- Graham N, Garrod A, Bullen P, et al. Placental expression of anti-angiogenic proteins in mirror syndrome: a case report. Placenta. 2012;33(6):528–531.
- Boyd PA, Lindenbaum RH, Redman C. Pre-eclampsia and trisomy 13: a possible association. Lancet. 1987;2(8556):425–427.
- Bdolah Y, Palomaki GE, Yaron Y, et al. Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol. 2006;194(1):239–245.